158 related articles for article (PubMed ID: 33830442)
1. Synchronous bilateral breast cancer treated with a 3-week hypofractionated radiotherapy schedule: clinical and dosimetric outcomes.
Gadea J; Ortiz I; Roncero R; Alastuey I; Mestre F; Aymar N; Maturana JE; Garcia C; Mateu L; Pardo J
Clin Transl Oncol; 2021 Sep; 23(9):1915-1922. PubMed ID: 33830442
[TBL] [Abstract][Full Text] [Related]
2. Synchronous bilateral breast cancer patients treated with hypofractionated bilateral breast irradiation: A dosimetric and clinical study.
Narasimhulu BC; Valiyaveettil D; Joseph D; Ahmed SF; Vijayakrishna E; Malik M
J Cancer Res Ther; 2020; 16(6):1309-1313. PubMed ID: 33342789
[TBL] [Abstract][Full Text] [Related]
3. Skin and lung toxicity in synchronous bilateral breast cancer treated with volumetric-modulated arc radiotherapy: a mono-institutional experience.
Valli M; Cima S; Gaudino D; Cartolari R; Deantonio L; Frapolli M; Daniele D; Pesce GA; Martucci F; Azinwi NC; Bosetti D; Presilla S; Richetti A
Clin Transl Oncol; 2019 Nov; 21(11):1492-1498. PubMed ID: 30875061
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric comparison of helical tomotherapy, volumetric-modulated arc therapy, intensity-modulated radiotherapy, and field-in-field technique for synchronous bilateral breast cancer.
Cheng HW; Chang CC; Shiau AC; Wang MH; Tsai JT
Med Dosim; 2020 Autumn; 45(3):271-277. PubMed ID: 32122694
[TBL] [Abstract][Full Text] [Related]
5. Synchronous bilateral breast cancer irradiation: clinical and dosimetrical issues using volumetric modulated arc therapy and simultaneous integrated boost.
Fiorentino A; Mazzola R; Naccarato S; Giaj-Levra N; Fersino S; Sicignano G; Tebano U; Ricchetti F; Ruggieri R; Alongi F
Radiol Med; 2017 Jun; 122(6):464-471. PubMed ID: 28224401
[TBL] [Abstract][Full Text] [Related]
6. Radiation therapy of synchronous bilateral breast carcinoma (SBBC) using multiple techniques.
Kim SJ; Lee MJ; Youn SM
Med Dosim; 2018 Spring; 43(1):55-68. PubMed ID: 28988893
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated radiotherapy in ten fractions for postmastectomy patients: a phase II study compared with another hypofractionation schedule with sixteen fractions.
Jiang H; Meng L; Zhang H; Dai X; Zhang Q; Ju Z; Yu W; Ma L
BMC Cancer; 2021 Dec; 21(1):1284. PubMed ID: 34852776
[TBL] [Abstract][Full Text] [Related]
8. Preliminary toxicity results using partial breast 3D-CRT with once daily hypo-fractionation and deep inspiratory breath hold.
Kowalchuk RO; Romano KD; Trifiletti DM; Dutta SW; Showalter TN; Morris MM
Radiat Oncol; 2018 Jul; 13(1):135. PubMed ID: 30053864
[TBL] [Abstract][Full Text] [Related]
9. Bilateral breast radiation delivered with static angle tomotherapy (TomoDirect): clinical feasibility and dosimetric results of a single patient.
Franco P; Migliaccio F; Torielli P; Sciacero P; Girelli G; Cante D; Arrichiello C; Casanova Borca V; Peruzzo Cornetto A; Numico G; La Porta MR; Tofani S; Ricardi U
Tumori; 2015 Mar; 101(1):e4-8. PubMed ID: 25702655
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Pulmonary Outcomes of a Feasibility Study of Inverse-Planned, Multibeam Intensity Modulated Radiation Therapy in Node-Positive Breast Cancer Patients Receiving Regional Nodal Irradiation.
Ho AY; Ballangrud A; Li G; Gupta GP; McCormick B; Gewanter R; Gelblum D; Zinovoy M; Mueller B; Mychalczak B; Dutta P; Borofsky K; Parhar P; Reyngold M; Braunstein LZ; Chawla M; Krause K; Freeman N; Siu CT; Cost Z; Arnold BB; Zhang Z; Powell SN
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1100-1108. PubMed ID: 30508620
[TBL] [Abstract][Full Text] [Related]
11. VMAT partial-breast irradiation: acute toxicity of hypofractionated schedules of 30 Gy in five daily fractions.
La Rocca E; Lozza L; D' Ippolito E; Dispinzieri M; Giandini C; Bonfantini F; Valdagni R; Folli S; Pignoli E; Di Cosimo S; De Santis MC
Clin Transl Oncol; 2020 Oct; 22(10):1802-1808. PubMed ID: 32128672
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated Radiotherapy With Simultaneous-integrated Boost After Breast-conserving Surgery Compared to Standard Boost-applications Using Helical Tomotherapy With TomoEdge.
Zwicker F; Hoefel S; Kirchner C; Huber PE; Debus J; Schempp M
Anticancer Res; 2021 Apr; 41(4):1909-1920. PubMed ID: 33813396
[TBL] [Abstract][Full Text] [Related]
13. Dosimetry and outcomes in patients receiving radiotherapy for synchronous bilateral breast cancers.
McKenzie E; Razvi Y; Bosnic S; Wronski M; Zhang L; Karam I; Donovan E; Milton L; Behroozian T; Drost L; Yee C; Wong G; Lam E; Chow E
J Med Imaging Radiat Sci; 2021 Dec; 52(4):527-543. PubMed ID: 34580051
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of optimal treatment planning for radiotherapy of synchronous bilateral breast cancer including regional lymph node irradiation.
Cho Y; Cho YJ; Chang WS; Kim JW; Choi WH; Lee IJ
Radiat Oncol; 2019 Apr; 14(1):56. PubMed ID: 30935400
[TBL] [Abstract][Full Text] [Related]
15. Intensity-modulated radiotherapy and hypofractionated volumetric modulated arc therapy for elderly patients with breast cancer: comparison of acute and late toxicities.
Fiorentino A; Gregucci F; Mazzola R; Figlia V; Ricchetti F; Sicignano G; Giajlevra N; Ruggieri R; Fersino S; Naccarato S; Massocco A; Corradini S; Alongi F
Radiol Med; 2019 Apr; 124(4):309-314. PubMed ID: 30547358
[TBL] [Abstract][Full Text] [Related]
16. [Subclinical heart injury in patients receiving hypofractionated radiotherapy after breast conserving surgery: a preliminary analysis of prospective study].
Chen SY; Wang SL; Tang Y; Zhang JH; Qin SR; Huan FK; Li TT; Fang H; Song YW; Jin J; Liu YP; Qi SN; Chen B; Tang Y; Li N; Lu NN; Li YX
Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):456-462. PubMed ID: 32575940
[No Abstract] [Full Text] [Related]
17. Reduction in low-dose to normal tissue with the addition of deep inspiration breath hold (DIBH) to volumetric modulated arc therapy (VMAT) in breast cancer patients with implant reconstruction receiving regional nodal irradiation.
Dumane VA; Saksornchai K; Zhou Y; Hong L; Powell S; Ho AY
Radiat Oncol; 2018 Sep; 13(1):187. PubMed ID: 30249274
[TBL] [Abstract][Full Text] [Related]
18. Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
Scorsetti M; Alongi F; Fogliata A; Pentimalli S; Navarria P; Lobefalo F; Garcia-Etienne C; Clivio A; Cozzi L; Mancosu P; Nicolini G; Vanetti E; Eboli M; Rossetti C; Rubino A; Sagona A; Arcangeli S; Gatzemeier W; Masci G; Torrisi R; Testori A; Alloisio M; Santoro A; Tinterri C
Radiat Oncol; 2012 Aug; 7():145. PubMed ID: 22929062
[TBL] [Abstract][Full Text] [Related]
19. Acute and intermediate toxicity of 3-week radiotherapy with simultaneous integrated boost using TomoDirect: prospective series of 287 early breast cancer patients.
Dicuonzo S; Leonardi MC; Raimondi S; Corrao G; Bagnardi V; Gerardi MA; Morra A; Zerella MA; Zaffaroni M; Pansini F; Cattani F; Luraschi R; Fodor C; Veronesi P; Orecchia R; Rojas DP; Jereczek-Fossa BA
Clin Transl Oncol; 2021 Jul; 23(7):1415-1428. PubMed ID: 33537865
[TBL] [Abstract][Full Text] [Related]
20. Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost.
Franceschini D; Fogliata A; Spoto R; Dominici L; Lo Faro L; Franzese C; Comito T; Lobefalo F; Reggiori G; Cozzi L; Sagona A; Gentile D; Scorsetti M
Radiother Oncol; 2021 Nov; 164():50-56. PubMed ID: 34537289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
